Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia

Study acronym: MTSA
StatusTerminated
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial terminated Sponsor's reason: Inclusion is proceeding too slowly Show 5 more changesShow less
    • Final enrollment: 12 participants (planned 21)
    • Primary completion date changed from estimate of Dec 31, 2025 to Jan 10, 2024
    • Study completion date changed from estimate of Dec 31, 2027 to Jul 4, 2024
    • Eligibility criteria expanded, about 10 words
    • Site details revised at 7 of 7 sites
  2. Primary completion date: Sep 30, 2024 to Dec 31, 2025
    • Study completion date: Dec 31, 2025 to Dec 31, 2027
    v10
  3. Primary completion date: Apr 30, 2024 to Sep 30, 2024v9
  4. Primary completion date: Dec 31, 2023 to Apr 30, 2024v8
  5. Phase: Phase 2 to Not applicable
    • Primary completion date: May 31, 2022 to Dec 31, 2023
    • Study completion date: May 31, 2024 to Dec 31, 2025
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Lead sponsor: Institut de Cancérologie de la Loire to Centre Hospitalier Universitaire de Saint Etiennev6 Show 4 more changesShow less
    • Primary completion date: May 31, 2021 to May 31, 2022
    • Study completion date: May 31, 2023 to May 31, 2024
    • Study sites revised (7)
    • Collaborators expanded, about 6 words
  2. Primary completion date: May 31, 2020 to May 31, 2021
    • Study sites: 6 to 7
    • Study completion date: May 31, 2022 to May 31, 2023
    v5
  3. Study sites: 2 to 6v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 1, 2018 to Jan 8, 2019
    • Site details revised at 2 of 2 sites
    v3
  5. Start date: Apr 1, 2018 to Oct 1, 2018v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims at evaluating the safety and the tolerance of the micro-transplantation in elderly patients with acute myeloid leukemia who are ineligible to conventional allogeneic transplantation.
Trial Details
NCT Number NCT03439371
Lead Sponsor Centre Hospitalier Universitaire de Saint Etienne
Collaborators: Institut de Cancérologie de la Loire
Conditions
(from sponsor)		 Acute Myeloid Leukemia
Related terms Leukemia, Myeloid, Acute
Enrollment 12 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov